You just read:

Altavant Sciences to Present Data Supporting Planned Phase 2 Clinical Program for Rodatristat Ethyl in Patients with Pulmonary Arterial Hypertension at PVRI World Congress

News provided by

Altavant Sciences

Jan 31, 2019, 08:00 ET